Oncology

In Depth

Personalised medicine demands diversity in clinical trials

Equity requires us to recognise and celebrate our differences, especially when it comes to health. To exemplify the need for diversity in clinical trials, Daniel Cook discusses what the underlying ra…

Comment And Analysis

Fermenting resistance

A study revealed that cancer cells that developed a high fermentative capacity became resistant and ceased responding to drug treatment, outlines Antonio Mazzocca.

Interviews

Evolving prostate cancer research with FFPE samples

Dr. Nallasivam Palanisamy of the Henry Ford Health System and Michigan State University and Dr. Han Wei of Beckman Coulter Life Sciences, who have been collaborating, together with their respective t…